Revenue $1,531m Up 55%EBITDA (underlying)
$763m Up 131%NPAT (underlying)
$430m Up 233%
With lot's more growth to come and spodumene/hydroxide price starting to take off. $50 in 2022 imo.
Ann: 2021 Financial Year - Half Year Results Presentation, page-4
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MIN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$45.86 |
Change
-1.390(2.94%) |
Mkt cap ! $9.012B | |||
| Open | High | Low | Value | Volume |
| $46.22 | $46.89 | $45.56 | $84.69M | 1.811M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2020 | $45.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $45.87 | 3192 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MIN (ASX) Chart |